Attention Deficit and Hyperactivity Disorder- treatment (MHS MRG 54)

Warning

Resources

Use the button below to access this item.

Access this resource

Editorial Information

Last reviewed: 14/01/2025

Next review date: 01/12/2026

Author(s): PMG-MH.

Version: 1

Approved By: PMG-MH

Reviewer name(s): Lead Clinical Pharmacist, Clinical Effectiveness Pharmacist.